Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Clancy

Showing results (221-230 of 226) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 226 results.
Neurology|December 8, 2006
Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe diseaseP S Kishnani, D Corzo, M Nicolino, et al.
The New England Journal of Medicine|November 19, 2010
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutationFrank J Accurso, Steven M Rowe, J P Clancy, et al.
Thorax|August 10, 2011
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutationJ P Clancy, Steven M Rowe, Frank J Accurso, et al.
JAMA Network Open|January 19, 2022
Comparison of Prolonged Exposure vs Cognitive Processing Therapy for Treatment of Posttraumatic Stress Disorder Among US Veterans: A Randomized Clinical TrialPaula P Schnurr, Kathleen M Chard, Josef I Ruzek, et al.
BMC Medical Research Methodology|April 28, 2019
Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosisTheodore G Liou, Frederick R Adler, Natalia Argel, et al.
Iscience|February 22, 2024
Airway inflammation accelerates pulmonary exacerbations in cystic fibrosisTheodore G Liou, Natalia Argel, Fadi Asfour, et al.
Pageof 23

Showing results (221-230 of 226) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 226 results.
Neurology|December 8, 2006
Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe diseaseP S Kishnani, D Corzo, M Nicolino, et al.
The New England Journal of Medicine|November 19, 2010
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutationFrank J Accurso, Steven M Rowe, J P Clancy, et al.
Thorax|August 10, 2011
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutationJ P Clancy, Steven M Rowe, Frank J Accurso, et al.
JAMA Network Open|January 19, 2022
Comparison of Prolonged Exposure vs Cognitive Processing Therapy for Treatment of Posttraumatic Stress Disorder Among US Veterans: A Randomized Clinical TrialPaula P Schnurr, Kathleen M Chard, Josef I Ruzek, et al.
BMC Medical Research Methodology|April 28, 2019
Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosisTheodore G Liou, Frederick R Adler, Natalia Argel, et al.
Iscience|February 22, 2024
Airway inflammation accelerates pulmonary exacerbations in cystic fibrosisTheodore G Liou, Natalia Argel, Fadi Asfour, et al.
Pageof 23